|23 January, 2020

Medical software company Evolucare Technologies presents its high-performance solutions at the ARAB HEALTH trade fair in Dubai 2020

The Group serves nearly 4,500 healthcare institutions, mostly in France, and has now the strategic aim of extending its reach to the international market.

Medical software company Evolucare Technologies presents its high-performance solutions at the ARAB HEALTH trade fair in Dubai 2020

United Arab Emirates :- Founded in 1988, EVOLUCARE Technologies is a French Healthcare IT company, leader in the development of medical information systems. The Group is offering a wide range of services satisfying the clinical, operational and financial needs of all healthcare institutions and facilities.

A dual ambition for Evolucare: artificial intelligence and the international market

The Group serves nearly 4,500 healthcare institutions, mostly in France, and has now the strategic aim of extending its reach to the international market. Drawing on its expertise in managing patient data and organizing care, Evolucare recently began the shift towards open innovation in digital health, especially AI and IoT, to add decision-making assistance services to its initial range through to the use of intelligent algorithms.

For its 5th appearance at the show, Evolucare will be presenting three of its new innovative solutions:

  • The HopitalWeb solution: a modular, web-based EHR system covering the whole patient workflow in hospital, clinics and outpatient centers. This feature-rich and highly configurable system offers a wide range of functionalities going from online appointment-scheduling to care management, OR and anesthesia management, pharmacy and stock management, administrative and HR management. Other modules such as stretcher-bearing, home care, meal management, etc. are also embedded.
  • The OphtAI – Ophcare ophthalmology solution, born after three years of research in artificial intelligence, enables automated screening for diabetic retinopathy, and soon other eye diseases – AMD and Glaucoma. This algorithm, ranked one of the most efficient algorithms in the world and winner of several awards, is paving the way for mass real-time, low-cost, and better-quality screening of retinal diseases, to which patients will enjoy easier and more equitable access.
  • the RIS imaging platform (Radiologic Information System) – PACS (Picture Archiving and Communication System) is a seamless web integrated imaging platform offering to all radiological departments and centers a wide range of cutting-edge functionalities.

Hadi Zarzour, the Group Area Manager of Evolucare, explains: “Over the last few years, our management has made it the priority to speed up our international growth. Our teams work in different geographical zones and operate in cooperation with organizations and experts in international expansion. Our strategy is premised on the skills transfer to local partners to create skills centers and, through them, meet the needs of every market in an optimal manner. Our product range is tailored to each segment and compliant with all relevant standards and regulations”.

Regarding the Emirates, he added: “We are in the process of building partnerships to promote our artificial intelligence products and our web HER and Imaging platforms”. 

Come see Evolucare at the France Pavilion organized by Business France at Arab Health, Stand Z2K36

-Ends-

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases